Today: 22 March 2026
Subscribe
Browse Category

Financial Forecasts 24 December 2025 - 25 December 2025

Gold Price Today: XAU/USD Holds Near $4,480 After Breaking $4,500 — Latest News, Drivers, and 2026 Forecasts (Dec. 25, 2025)

Gold Price Today: XAU/USD Holds Near $4,480 After Breaking $4,500 — Latest News, Drivers, and 2026 Forecasts (Dec. 25, 2025)

Gold hit an intraday record near $4,525 per ounce on Christmas Eve before settling around $4,479 in thin holiday trading. The late-year surge follows expectations of U.S. rate cuts, a weaker dollar, and safe-haven demand amid geopolitical tensions. Major banks forecast gold in 2026 between the low $4,000s and above $5,000, depending on rates and global risks.
25 December 2025
··
Mastercard (MA) Stock After Hours Today (Dec. 25, 2025): Latest News, Forecasts, and What to Know Before the Market Opens Tomorrow

Mastercard (MA) Stock After Hours Today (Dec. 25, 2025): Latest News, Forecasts, and What to Know Before the Market Opens Tomorrow

Mastercard shares last closed at $579.45 on Dec. 24 in a holiday-shortened session, with after-hours trading showing a slight dip of $0.30. U.S. markets were closed Dec. 25 for Christmas. Mastercard’s SpendingPulse data showed U.S. holiday retail sales up 3.9% year over year, topping company forecasts. Trading resumes Dec. 26.
25 December 2025
··
Pfizer (PFE) Stock News, Forecasts and Analyst Outlook as of Dec. 25, 2025

Pfizer (PFE) Stock News, Forecasts and Analyst Outlook as of Dec. 25, 2025

Pfizer shares closed at $25.03 on Dec. 24, ahead of Christmas, after the company issued 2026 guidance below Wall Street forecasts. The drugmaker projected 2026 revenue of $59.5–$62.5 billion and adjusted EPS of $2.80–$3.00, citing lower COVID product sales and loss of exclusivity. Pfizer declared a $0.43 per share Q1 2026 dividend, its 349th consecutive payout.
25 December 2025
···
Intel Stock (INTC) News, Forecasts, and Analyst Outlook for Dec. 25, 2025: Nvidia’s 18A Pause, a U.S. Government Stake, and What Comes Next

Intel Stock (INTC) News, Forecasts, and Analyst Outlook for Dec. 25, 2025: Nvidia’s 18A Pause, a U.S. Government Stake, and What Comes Next

Intel shares closed at $36.18 on Dec. 24, down 0.56%, after reports that Nvidia tested but paused work with Intel’s advanced 18A chip process. The stock remains about 18% below its 52-week high. Intel said 18A development is on track and interest continues. U.S. markets are closed Dec. 25 for Christmas.
25 December 2025
··
D-Wave Quantum (QBTS) Stock News Today: CES 2026 Catalyst, Analyst Forecasts, and a Reality Check on Valuation

D-Wave Quantum (QBTS) Stock News Today: CES 2026 Catalyst, Analyst Forecasts, and a Reality Check on Valuation

D-Wave Quantum stock closed at $27.52 on Dec. 24, down 5.5% after a volatile week that saw a surge to $32.10 on news it will showcase commercial quantum tech at CES 2026. The company plans to sponsor CES Foundry in January and hold its Qubits 2026 conference later that month, focusing on technical updates and customer adoption.
25 December 2025
··
Ondas Holdings (ONDS) Stock: Latest News, Analyst Forecasts, and What’s Driving the Defense-Tech Story (Dec. 25, 2025)

Ondas Holdings (ONDS) Stock: Latest News, Analyst Forecasts, and What’s Driving the Defense-Tech Story (Dec. 25, 2025)

Ondas Holdings last traded near $9.07 in a shortened session on Dec. 24, 2025, after announcing two $8.2 million counter-UAS airport orders in Europe in November and December. The company also secured a national border-protection tender on Dec. 3, involving deployment of thousands of autonomous drones. Investors remain focused on Ondas’ ability to integrate acquisitions and scale operations.
25 December 2025
···
UiPath Stock (PATH) Surges Ahead of S&P MidCap 400 Addition: Latest News, Forecasts, and What Comes Next

UiPath Stock (PATH) Surges Ahead of S&P MidCap 400 Addition: Latest News, Forecasts, and What Comes Next

S&P Dow Jones Indices said UiPath will replace Synovus Financial in the S&P MidCap 400 on January 2, 2026, following Synovus’ acquisition by Pinnacle Financial. UiPath shares closed at $17.16 in the shortened Christmas Eve session. Analysts now debate valuation and forecast a “Hold” consensus, with a $16 average target and recent insider selling noted. Markets were closed December 25 for Christmas.
25 December 2025
··
Bristol-Myers Squibb (BMY) Stock News, Forecasts and Outlook as of Dec. 25, 2025: Breyanzi FDA Win, Eliquis Medicaid Deal, and 2026 Catalysts

Bristol-Myers Squibb (BMY) Stock News, Forecasts and Outlook as of Dec. 25, 2025: Breyanzi FDA Win, Eliquis Medicaid Deal, and 2026 Catalysts

Bristol-Myers Squibb closed at $54.71 on Dec. 24, 2025, after trading between $54.20 and $54.75, with a 52-week range of $42.52 to $63.33. The company agreed to provide Eliquis free to Medicaid starting in 2026 and will donate over seven tons of Eliquis API to the U.S. government. BMS also announced steep discounts for several drugs and secured three years of tariff relief.
25 December 2025
···
Analog Devices (ADI) Stock News Today: Price Hike Reports, Analyst Forecasts, and 2026 Outlook as of Dec. 25, 2025

Analog Devices (ADI) Stock News Today: Price Hike Reports, Analyst Forecasts, and 2026 Outlook as of Dec. 25, 2025

Analog Devices ended Dec. 24 trading at $277.56, near recent highs, with U.S. markets closed for Christmas. The company reported fiscal 2025 revenue of $11.0 billion, up 17%, and plans to raise prices starting Feb. 1, 2026. ADI guided Q1 2026 revenue to $3.1 billion, with adjusted EPS of $2.29. Investors are watching the impact of the price increase on margins and demand.
25 December 2025
·
Cadence Design Systems (CDNS) Stock: Latest News, Forecasts, and 2026 Catalysts as of December 25, 2025

Cadence Design Systems (CDNS) Stock: Latest News, Forecasts, and 2026 Catalysts as of December 25, 2025

Cadence Design Systems last traded near $318 on Dec. 24, following a year of earnings beats, raised guidance, and volatility from U.S.-China policy shifts. The company reported Q3 revenue of $1.339 billion, non-GAAP EPS of $1.93, and a record $7 billion backlog. Cadence raised full-year 2025 guidance but projected Q4 EPS slightly below analyst consensus. U.S. markets were closed Dec. 25 for Christmas.
25 December 2025
··
Salesforce (CRM) Stock News Today (Dec. 25, 2025): Agentforce AI Momentum, Analyst Price Targets, and the 2026 Outlook

Salesforce (CRM) Stock News Today (Dec. 25, 2025): Agentforce AI Momentum, Analyst Price Targets, and the 2026 Outlook

Salesforce shares closed at $265.26 on December 24, down about 21% for 2025 despite a December rebound. Barron’s highlights strong Agentforce ARR growth and improved margins but notes valuation remains below peers. Simply Wall St points to deeper adoption in regulated sectors. MarketBeat reports institutional investors, including Brookstone Capital, increased positions in recent filings.
25 December 2025
·
Intel Stock (INTC) Outlook for 2026: Nvidia’s 18A Pause, U.S. Government Stake, and Analyst Forecasts (Dec. 25, 2025)

Intel Stock (INTC) Outlook for 2026: Nvidia’s 18A Pause, U.S. Government Stake, and Analyst Forecasts (Dec. 25, 2025)

Intel shares swung sharply in thin holiday trading Dec. 24, closing near $36.15 after reports said Nvidia stopped moving forward with testing Intel’s 18A chip manufacturing process. The news renewed debate over Intel’s execution in advanced manufacturing. Despite the setback, Nvidia remains financially tied to Intel through a $5 billion investment cleared by U.S. antitrust agencies.
25 December 2025
···
Shell Plc (SHEL) Stock News on Dec. 25, 2025: Buybacks, Gulf Discovery, and 2026 Forecasts in Focus

Shell Plc (SHEL) Stock News on Dec. 25, 2025: Buybacks, Gulf Discovery, and 2026 Forecasts in Focus

Shell’s U.S.-listed shares closed at $72.84 on Dec. 24, down 0.31% ahead of the Christmas break. The company disclosed new share buybacks on Dec. 24 as part of its ongoing $3.5 billion program. Shell also reported a new oil discovery at the Nashville well in the U.S. Gulf of Mexico, operated with a 79% stake. Markets in the U.S. and UK are closed Dec. 25 for the holiday.
25 December 2025
··
Vedanta Limited Share Price Today: VEDL Near 52-Week High as Demerger Countdown Fuels Fresh Stock Forecasts for 2026

Vedanta Limited Share Price Today: VEDL Near 52-Week High as Demerger Countdown Fuels Fresh Stock Forecasts for 2026

Vedanta shares closed at ₹598.15 on December 24, just below a 52-week high, as markets shut for Christmas on December 25. The National Company Law Tribunal has approved Vedanta’s plan to split into five listed entities, with the power unit’s order still pending. CRISIL kept some ratings on “Watch Developing” citing unresolved details on debt and asset allocation. Vedanta aims to complete the demerger by March 2026.
25 December 2025
···
Chubb Limited (CB) Stock After the Bell on Dec. 24, 2025: After-Hours Move, Today’s Forecasts, and What to Watch Before the Dec. 26 Open

Chubb Limited (CB) Stock After the Bell on Dec. 24, 2025: After-Hours Move, Today’s Forecasts, and What to Watch Before the Dec. 26 Open

Chubb Limited closed flat at $313.32 in a shortened session Dec. 24, with light volume before ticking up to $314.53 in after-hours trading. U.S. markets will remain closed Dec. 25, with the next session on Dec. 26. The stock trades near 52-week highs as analysts set Q4 EPS expectations at $6.33. Early close and thin liquidity marked today’s trading.
25 December 2025
··
Salesforce (CRM) Stock After the Bell on Dec. 24, 2025: Today’s Price Action, Fresh Forecasts, and What to Know Before the Next Market Open

Salesforce (CRM) Stock After the Bell on Dec. 24, 2025: Today’s Price Action, Fresh Forecasts, and What to Know Before the Next Market Open

Salesforce shares closed at $265.26, up 0.68% in a holiday-shortened session on Dec. 24, with light after-hours trading and no major company news. U.S. stock indexes hit new highs as jobless claims fell to 214,000. Markets will be closed Dec. 25 for Christmas and reopen Dec. 26.
24 December 2025
···
Regencell Bioscience Holdings (NASDAQ: RGC) Stock News Today: Price Action, DOJ Probe Overhang, and the Latest Forecasts on Dec. 24, 2025

Regencell Bioscience Holdings (NASDAQ: RGC) Stock News Today: Price Action, DOJ Probe Overhang, and the Latest Forecasts on Dec. 24, 2025

Regencell Bioscience (RGC) closed at $24.60 on Dec. 24, down 2.57%, with about 348,000 shares traded and a market cap near $12.16 billion. The stock remains volatile amid concentrated insider ownership, a DOJ inquiry into trading, and no reported revenue. The company focuses on Traditional Chinese Medicine for neurocognitive disorders, with operations in Hong Kong.
24 December 2025
·
1 2 3 4 5 6 … 42

Stock Market Today

  • Nasdaq Valuation Perspective Amid SEC's Tokenized Securities Approval
    March 21, 2026, 8:36 PM EDT. Nasdaq (NDAQ) gains attention after the U.S. SEC approved trading and settlement of certain Nasdaq-listed securities in tokenized blockchain form, in partnership with Payward. The stock shows mixed recent performance: up 6.06% over one month but down 10.68% year-to-date. Long-term returns remain robust, with 15.67% over one year and 83.91% over five years. Analysts place Nasdaq's fair value at $108.53, implying the current $86.34 share price could be undervalued by about 20%. This estimate factors in growth projections, AI-related demand, and fintech platform strength. Yet, valuation risks remain from potential competition and client decision slowdowns. Nasdaq's price-to-earnings ratio at 27.4x exceeds a fair ratio of 16.2x, signaling possible investor caution if market sentiment shifts.
Go toTop